a developer of therapeutics based on RNA interference
Industry Biotechnology
A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.
Ticker / NAME | Correlation To ALNY | 1D Price Change % | ||
---|---|---|---|---|
ALNY | 100% | -2.53% | ||
IONS - ALNY | 45% Loosely correlated | -1.46% | ||
DNA - ALNY | 30% Poorly correlated | -15.00% | ||
AUPH - ALNY | 30% Poorly correlated | +0.60% | ||
GLYC - ALNY | 30% Poorly correlated | -0.65% | ||
ABOS - ALNY | 30% Poorly correlated | +3.16% | ||
More |
Ticker / NAME | Correlation To ALNY | 1D Price Change % |
---|---|---|
ALNY | 100% | -2.53% |
therapy theme (23 stocks) | 58% Loosely correlated | -7.42% |
drugs theme (254 stocks) | 40% Loosely correlated | -4.03% |
biotechnology theme (238 stocks) | 20% Poorly correlated | -4.32% |